Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David F Fiorentino

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Journal of the American Academy of Dermatology|March 15, 2003
Cutaneous vasculitisDavid F Fiorentino
Archives of Dermatology|February 21, 2007
The Yin and Yang of TNF-{alpha} inhibitionDavid F Fiorentino
Archives of Dermatology|October 22, 2008
Type I interferon in the induction or exacerbation of dermatomyositis: what this observation tells us about the naturally occurring diseaseDavid F Fiorentino
Seminars in Cutaneous Medicine and Surgery|December 19, 2006
Update on cutaneous vasculitisTatiana M Grzeszkiewicz, David F Fiorentino
Current Opinion in Rheumatology|August 22, 2012
Skin disease in dermatomyositisLisa C Zaba, David F Fiorentino
Clinical Reviews in Allergy & Immunology|May 20, 2022
Autoantibodies and Cancer Association: the Case of Systemic Sclerosis and DermatomyositisDavid F Fiorentino, Livia Casciola-Rosen
Current Rheumatology Reports|November 5, 2014
Amyopathic dermatomyositis: definitions, diagnosis, and managementElizabeth E Bailey, David F Fiorentino
Current Rheumatology Reports|April 12, 2018
Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific AutoantibodiesPaige W Wolstencroft, David F Fiorentino
International Journal of Rheumatology|November 29, 2011
Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic SclerosisKait Arefiev, David F Fiorentino, Lorinda Chung
Indian Journal of Dermatology|November 1, 2012
Clinical presentation and evaluation of dermatomyositisUmaima Marvi, Lorinda Chung, David F Fiorentino
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Journal of the American Academy of Dermatology|March 15, 2003
Cutaneous vasculitisDavid F Fiorentino
Archives of Dermatology|February 21, 2007
The Yin and Yang of TNF-{alpha} inhibitionDavid F Fiorentino
Archives of Dermatology|October 22, 2008
Type I interferon in the induction or exacerbation of dermatomyositis: what this observation tells us about the naturally occurring diseaseDavid F Fiorentino
Seminars in Cutaneous Medicine and Surgery|December 19, 2006
Update on cutaneous vasculitisTatiana M Grzeszkiewicz, David F Fiorentino
Current Opinion in Rheumatology|August 22, 2012
Skin disease in dermatomyositisLisa C Zaba, David F Fiorentino
Clinical Reviews in Allergy & Immunology|May 20, 2022
Autoantibodies and Cancer Association: the Case of Systemic Sclerosis and DermatomyositisDavid F Fiorentino, Livia Casciola-Rosen
Current Rheumatology Reports|November 5, 2014
Amyopathic dermatomyositis: definitions, diagnosis, and managementElizabeth E Bailey, David F Fiorentino
Current Rheumatology Reports|April 12, 2018
Dermatomyositis Clinical and Pathological Phenotypes Associated with Myositis-Specific AutoantibodiesPaige W Wolstencroft, David F Fiorentino
International Journal of Rheumatology|November 29, 2011
Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic SclerosisKait Arefiev, David F Fiorentino, Lorinda Chung
Indian Journal of Dermatology|November 1, 2012
Clinical presentation and evaluation of dermatomyositisUmaima Marvi, Lorinda Chung, David F Fiorentino
Pageof 6